Phosphoglycerate mutase 1 reduces neuronal damage in the hippocampus following ischemia/reperfusion through the facilitation of energy utilization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Woosuk | - |
dc.contributor.author | Kwon, Hyun Jung | - |
dc.contributor.author | Jung, Hyo Young | - |
dc.contributor.author | Yoo, Dae Young | - |
dc.contributor.author | Kim, Dae Won | - |
dc.contributor.author | Hwang, In Koo | - |
dc.date.accessioned | 2021-08-11T08:37:53Z | - |
dc.date.available | 2021-08-11T08:37:53Z | - |
dc.date.issued | 2020-02 | - |
dc.identifier.issn | 0197-0186 | - |
dc.identifier.issn | 1872-9754 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/3145 | - |
dc.description.abstract | In a previous study, we observed the effect of phosphoglycerate mutase 1 (PGAM1) on proliferating cells and neuroblasts in the subgranular zone of mouse dentate gyrus. In the present study, we examined the roles of PGAM1 in the HT22 hippocampal cell line and in gerbil hippocampus after H2O2-induced oxidative stress and after ischemia/reperfusion, respectively. Control-PGAM1 and Tat-PGAM1 proteins were synthesized using Tat-1 expression vector since Tat-1 fusion proteins can easily cross the blood-brain barrier and cell membranes. We found that transduction of Tat-PGAM1 protein into HT22 cells was dose- and time-dependent. Delivery of the protein to the cytoplasm was confirmed by western blotting and immunocytochemistry. Treatment of HT22 cells with Tat-PGAM1 protein showed a concentration-dependent reduction in cell damage and decreased formation of reactive oxygen species after H2O2 exposure. Tat-PGAM1 administration significantly ameliorated the ischemia-induced hyperactivity in gerbils at 1 day after ischemia/reperfusion. Additionally, a pronounced decrease in neuronal damage and reactive gliosis were observed in the hippocampal CA1 region of the Tat-PGAM1-treated group at 4 days after ischemia/reperfusion compared to that in the vehicle (Tat peptide) or control-PGAM1-treated groups. Administration of Tat-PGAM1 mitigated the changes in ATP content, succinate dehydrogenase activity, pH, and 4-hydroxynonenal levels in the hippocampus at 4 and 7 days after ischemia/reperfusion compared to that in the vehicle-treated group. In addition, administration of Tat-PGAM1 significantly ameliorated the ischemia-induced increases of lactate levels in the hippocampus at 15 min and 6 h after ischemia/reperfusion than in the vehicle or control-PGAM1-treated groups. These results suggest that TatPGAM1 can be used as a therapeutic agent to prevent neuronal damage from oxidative stress or ischemia. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Phosphoglycerate mutase 1 reduces neuronal damage in the hippocampus following ischemia/reperfusion through the facilitation of energy utilization | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.neuint.2019.104631 | - |
dc.identifier.scopusid | 2-s2.0-85076243023 | - |
dc.identifier.wosid | 000509615900012 | - |
dc.identifier.bibliographicCitation | Neurochemistry International, v.133 | - |
dc.citation.title | Neurochemistry International | - |
dc.citation.volume | 133 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | CEREBRAL-ISCHEMIA | - |
dc.subject.keywordPlus | SUCCINATE-DEHYDROGENASE | - |
dc.subject.keywordPlus | SPREADING DEPRESSION | - |
dc.subject.keywordPlus | GLYCOLYTIC-ENZYMES | - |
dc.subject.keywordPlus | LOCOMOTOR-ACTIVITY | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordPlus | ALZHEIMERS | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordAuthor | Phosphoglycerate mutase 1 | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.subject.keywordAuthor | Ischemia | - |
dc.subject.keywordAuthor | Gerbil | - |
dc.subject.keywordAuthor | Energy production | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.